ITGA5 and breast cancer: To set up the workflow, activated HMFs (representing CAFs) and MDA-MB-231 breast cancer cells were mixed and processed through the microsieve system, followed by fluorophore-conjugated antibody of FAP, ITGA5 and pan-CK incubation.